Title : Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy.

Pub. Date : 2022 Apr

PMID : 35496952






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ibrutinib is one of these treatments and acts by inhibiting bruton tyrosine kinase. ibrutinib Bruton tyrosine kinase Homo sapiens